Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
Go back to Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study| Revere Bank Laurel MD Com (NASDAQ: REVB) | Delayed: 0.99 -0.01 (1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $16.00 | |||
| Open | $1.00 | 52 Week Low | $10.65 | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $0.99 | EPS | $0.00 | |||
| Volume | 3,618 | |||||
